QUIDELORTHO CORP Increase (Decrease) in Other Operating Liabilities
QUIDELORTHO CORP (QDEL) reported Increase (Decrease) in Other Operating Liabilities of -$86.90 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-07
- QUIDELORTHO CORP increase (decrease) in other operating liabilities for the quarter ending 2026-06-28 was -$17.90M.
- QUIDELORTHO CORP increase (decrease) in other operating liabilities for the quarter ending 2026-03-29 was -$69.00M.
- QUIDELORTHO CORP increase (decrease) in other operating liabilities for the quarter ending 2025-12-28 was $100.80M.
- QUIDELORTHO CORP increase (decrease) in other operating liabilities for the quarter ending 2025-09-28 was $24.00M, a 44.70% decline year-over-year.
- QUIDELORTHO CORP increase (decrease) in other operating liabilities for fiscal 2025 was $92.00M.
- QUIDELORTHO CORP increase (decrease) in other operating liabilities for fiscal 2024 was -$22.60M.
- QUIDELORTHO CORP increase (decrease) in other operating liabilities for fiscal 2023 was -$5.90M.
- QUIDELORTHO CORP increase (decrease) in other operating liabilities for fiscal 2023 was -$75.20M, a 369.53% decline from fiscal 2022.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$17.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$86.90M 10-Q · filed 2026-08-07 | $13.90M derived: sum of 3 quarters · filed 2026-08-07 | $37.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | -$69.00M 10-Q · filed 2026-05-06 | $31.80M derived: sum of 2 quarters · filed 2026-05-06 | $55.80M derived: sum of 3 quarters · filed 2026-05-06 | $39.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $100.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $124.80M derived: sum of 2 quarters · filed 2026-02-19 | $108.90M derived: sum of 3 quarters · filed 2026-08-07 | $92.00M 10-K · filed 2026-02-19 |
| 2025-09-28 | $24.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.10M derived: sum of 2 quarters · filed 2026-08-07 | -$8.80M 10-Q · filed 2025-11-06 | -$21.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | -$15.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$32.80M 10-Q · filed 2026-08-07 | -$45.00M derived: sum of 3 quarters · filed 2026-08-07 | -$1.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | -$16.90M 10-Q · filed 2026-05-06 | -$29.10M derived: sum of 2 quarters · filed 2026-05-06 | $14.30M derived: sum of 3 quarters · filed 2026-05-06 | $22.00M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | -$12.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $31.20M derived: sum of 2 quarters · filed 2026-02-19 | $38.90M derived: sum of 3 quarters · filed 2026-02-19 | -$22.60M 10-K · filed 2026-02-19 |
| 2024-09-29 | $43.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $51.10M derived: sum of 2 quarters · filed 2025-11-06 | -$10.40M 10-Q · filed 2025-11-06 | -$12.20M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$53.80M 10-Q · filed 2025-08-06 | -$55.60M derived: sum of 3 quarters · filed 2026-02-19 | -$26.30M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$61.50M 10-Q · filed 2025-05-08 | -$63.30M derived: sum of 2 quarters · filed 2026-02-19 | -$34.00M derived: sum of 3 quarters · filed 2026-02-19 | -$70.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $27.50M derived: sum of 2 quarters · filed 2026-02-19 | -$9.20M derived: sum of 3 quarters · filed 2026-02-19 | -$5.90M 10-K · filed 2026-02-19 |
| 2023-10-01 | $29.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$7.40M derived: sum of 2 quarters · filed 2024-11-08 | -$4.10M 10-Q · filed 2024-11-08 | $32.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$36.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$33.40M 10-Q · filed 2024-08-01 | $2.70M derived: sum of 3 quarters · filed 2025-02-27 | -$79.60M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $3.30M 10-Q · filed 2024-05-09 | $39.40M derived: sum of 2 quarters · filed 2025-02-27 | -$42.90M derived: sum of 3 quarters · filed 2025-02-27 | -$59.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $36.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$46.20M derived: sum of 2 quarters · filed 2025-02-27 | -$63.00M derived: sum of 3 quarters · filed 2025-02-27 | -$75.20M 10-K · filed 2025-02-27 |
| 2022-10-02 | -$82.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$99.10M derived: sum of 2 quarters · filed 2023-11-02 | -$111.30M 10-Q · filed 2023-11-02 | -$109.40M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | -$16.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$29.00M 10-Q · filed 2023-08-09 | -$27.10M derived: sum of 3 quarters · filed 2024-08-01 | -$2.60M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | -$12.20M 10-Q · filed 2023-05-04 | -$10.30M derived: sum of 2 quarters · filed 2024-08-01 | $14.20M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $1.90M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $26.40M derived: sum of 2 quarters · filed 2024-08-01 | $27.90M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | $24.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $26.00M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $1.50M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $14.20M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |